February 2022 - PsychedelicNewsWire (PNW)

MondayFeb 28, 2022 10:29 am

At-Home Ketamine Treatments for Mental Disorders Boom in US

Ketamine for the treatment of various mental health conditions, particularly depression, is growing in the United States. However, while the ease of prescription rules is fueling increases in drug offerings, some experts are concerned that this may cause a regulatory crackdown, as the long-term impact of this particular anesthetic hasn’t been well studied. Boris Heifets, an assistant professor of anesthesiology at Stanford University, explained that it would be better if the drug was slowly rolled out to better implement a much more integrated approach to mental health. Ketamine, which was once a taboo party drug, has been available in the…

MondayFeb 28, 2022 9:45 am

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Tackles Pandemic-era Mental Health Crises with Product R&D and Educational Efforts for the Application of Psychedelics Technology

Delic Holdings Corp is a leader in new medicines and treatments for a modern world with a focus on improving access to health benefits across the country through an integrated, scalable approach to meeting patients’ mental wellness needs Delic has built a three-pronged ecosystem that includes Ketamine Wellness Centers (“KWC”), the largest chain of wellness clinics providing ketamine treatments in the U.S.; Reality Sandwich and Meet Delic, media properties providing education on psychedelics; and DELIC Labs, a federally-authorized research facility The company’s CSO has spoken at a number of conferences on the importance of controlling the extraction production processes for…

MondayFeb 28, 2022 9:15 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Makes Exciting Drug Discovery for the Treatment of Mental health and Addiction Disorders – MYCO-005

Mydecine announced the inclusion of a patent-pending novel molecule in its family of psilocin analogs, MYCO-005 This molecule features potentially heart-safe microdose-enabling properties, addressing the delivery and stability concerns associated with the first-generation compounds Mydecine’s patent-pending dermal route to administration also offers more control over the drug while possibly eliminating undesirable properties such as nausea The company is excited about this finding, terming it one of the many exciting drug discoveries it looks to share in the near term Microdosing, the act of consuming a minimal dose of a psychedelic to benefit from what it offers without going through a…

FridayFeb 25, 2022 1:49 pm

Psychedelic Therapeutics Market May Receive Federal Approval Before Marijuana Does

In a recent interview, Palo Santo cofounder and partner Tim Schlidt stated that he believed that the federal legalization pathway for psychedelics was much smoother than cannabis’ approach. Palo Santo is a psychedelic investment fund, and Schildt has been working to help increase the supply of clinically effective and accessible addiction and mental health treatment solutions. This comes as psychedelic therapeutics gain more recognition in the mainstream medical space. However, there’s still concern that these treatments may have negative outcomes in the longterm. When asked about whether the psychedelic therapeutics market could in the future outpace the marijuana market, Schlidt…

ThursdayFeb 24, 2022 3:50 pm

VIU Set to Launch First Psychedelics Therapy Course in Canada

Vancouver Island University (“VIU”) plans to launch its psychedelic-assisted therapy course in September of this year. This will make it the first accredited university in Canada to offer this course for healthcare professionals, under its Faculty of Health and Human Services. Shannon Dames, the institution’s nursing professor, stated that this launch was significant because it recognized that psychedelic-assisted therapy was an advanced practice that required a unique skill set. Laura McLean, one of the program’s registrants, signed up after she tried therapy under Roots to Thrive. Roots to Thrive is a 12-week program with virtual sessions that feature guided discussions…

WednesdayFeb 23, 2022 2:31 pm

A Review of Recent Moves Made by Psychedelic Companies

A lot has happened over the past weeks in the psychedelics industry. Below, we look at some of the moves companies in this burgeoning sector have made. Last week, Core One Labs Inc. researchers at its Vocan Biotechnologies Inc. subsidiary had received positive results and would begin using its recombinant production system to produce API-Grade N-methyltryptamine, or NMT. NMT is also known as MMT, or monomethyl tryptamine, and is a DMT precursor that the company will be producing to expand its psychedelic product pipeline. The firm is currently using its proprietary recombinant production system to produce psilocybin. In a recent…

WednesdayFeb 23, 2022 10:15 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Communicating the Therapeutic Benefits of Psychedelics; Advocating for Accurate and Consistent Messaging to Promote The Acceptance of Psychedelics in Therapeutics

Studies suggest that psychedelics such as psilocybin and MDMA offer health benefits when used to treat patients with depression and PTSD These results have encouraged scientists, psychotherapists, and entrepreneurs, who say that FDA approvals may be on the horizon Mydecine is playing a vital role in pushing the knowledge of the benefits of psychedelic compounds by undertaking clinical research in partnership with academics In a recent interview, company CEO Josh Bartch emphasized the need for consistent messaging to push the adoption of psychedelics among the medical community, and help assuage concerns of patients who may be wary of psychedelic treatments…

TuesdayFeb 22, 2022 2:28 pm

Insights into Life and Psychedelics from Psychedelics Pioneers

Psychedelics pioneers have for many years argued that the substances enhance perception in a way that is healing and extraordinary. Below are powerful insights into human nature from a couple of psychonaut academics, writers and philosophers. Anaïs Nin Anaïs Nin was a French-Cuban-American writer who was consulted by doctors to improve their understanding of LSD’s effects. Nin participated in an LSD experiment in the fall of 1955, which was carried out by Oscar Janiger, an experimental psychiatrist best known for his research on LSD. Nin described the experience as the most pleasurable sensation she’d ever known, noting that it was…

TuesdayFeb 22, 2022 9:00 am

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Seeks to Capitalize on the Growing Market for Psychedelics in Healthcare

The global psychedelics market is estimated to hit $10.75 billion in 2027, with the alternative antidepressant drug market being valued at $15.98 billion in 2023 Already, 65% of individuals dealing with PTSD, depression, and anxiety in the United States believe that psychedelic medicine should be made available 83% of Americans living with these conditions are open to trying out alternative treatments Delic seeks to capitalize on this growing demand for psychedelic alternatives, coupled with ongoing legislative and regulatory changes to grow its brand and increase value for its shareholders While the psychedelics industry might be in its early stages, its…

FridayFeb 18, 2022 1:04 pm

Study Finds That Psychedelics Can Alter Core Metaphysical Beliefs

A new study has found that psychedelic substances can alter an individual’s core beliefs about the nature of free will, consciousness and reality. The study’s findings were reported in the “Scientific Reports” journal. The researchers’ objective was to find out whether psychedelics had the capacity to change a person’s core metaphysical beliefs, because the drugs can induce spiritual encounters and transformative experiences. Metaphysical beliefs are ideas about reality’s fundamental nature. The study was carried out by a team of researchers led by Christopher Timmermann, who examined the metaphysical beliefs of participants before and after they had used psychedelics. The researchers…

News and publishing service for psychedelic related companies

Contact us: 415.949.5050

Month: February 2022